Portfolio demo. A read-only sample fund.

Portfolio Demo
Portfolio

GreenLeaf Bio

Fund I
Seed
Biotech
Cash: $1.5M(Q4 2025)
Analyst

Metrics

Cash on Hand

Q1 2025Q2 2025Q3 2025Q4 2025$0$600K$1.2M$1.8M$2.4M

Headcount

Q1 2025Q2 2025Q3 2025Q4 20250481216
Invested: $750,000FMV: $997,500Gross MOIC: 1.33xGross IRR: 11.0%as of
VehicleTypeRoundDateInvestedSharesPriceFMV
Fund I
Investment
SeedJan 10, 2024$750,000750,000$1.00$997,500
Fund I
Valuation Update
-Dec 31, 2025--$1.33$250,000

No reporting updates captured yet. Updates appear here when a portfolio-reporting email is assigned to this company.

No documents or email activity yet. Upload a file here, or process an email for this company.

Recent Interactions

View all
Jun 11

FDA pre-submission feedback

Priya shared positive feedback from FDA pre-submission meeting. Regulatory pathway looks clearer than expected. Team targeting Q2 2026 for clearance filing.

Founders

Dr. Priya Patel

Overview

Developing sustainable bio-based alternatives to petroleum-derived packaging materials.

Why We Invested

Breakthrough polymer technology with strong IP moat and massive market opportunity.